Skip to main content

Advertisement

SpringerLink
Log in

Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The authors describe a young patient affected by long-standing polymyositis refractory to conventional treatment who showed a rapid and striking response to mycophenolate mofetil treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chan TM, Li FK, Tang CS et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong–Guangzhou Nephrology Study Group. N Engl J Med 343:1156–1162

    Article  PubMed  CAS  Google Scholar 

  2. Majithia V, Harisdangkul V (2005) Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology 44:386–389

    Article  PubMed  CAS  Google Scholar 

  3. Gelber AC, Nousari HC, Wigley FM (2000) Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 27:1542–1545

    PubMed  CAS  Google Scholar 

  4. Rowin J, Amato AA, Deisher N, Cursio J, Meriggioli MN (2006) Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66:1245–1247

    Article  PubMed  CAS  Google Scholar 

  5. Waldman MA, Callen JP (2004) Self-resolution of Epstein–Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. J Am Acad Dermatol 51 (Suppl 2):S124–S130

    Article  PubMed  Google Scholar 

  6. Edge JC, Outland JD, Dempsey JR, Callen JP (2006) Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 142:65–69

    Article  PubMed  CAS  Google Scholar 

  7. Labioche I, Liozon E, Weschler B, Loustaud-Ratti V, Soria P, Vidal E (2004) Refractory polymyositis responding to infliximab: extended follow-up. Rheumatology 43:531–532

    Article  PubMed  CAS  Google Scholar 

  8. Saadeh CK (2000) Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroid and other disease modifying agents. Arthritis Rheum 43:S193

    Google Scholar 

  9. Hengstam GJD, Van Der Hoogen FHJ, Barbera P et al (2003) Anti-TNF blockade with infliximab (Remicade) in polymyositis and dermatomyositis. Eur Neurol 50:10–15

    Article  Google Scholar 

  10. Uthman I, El-Sayad J (2004) Refractory polymyositis responding to infliximab. Rheumatology 43:1198–1199

    Article  PubMed  CAS  Google Scholar 

  11. Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology 44:562–563

    Article  PubMed  CAS  Google Scholar 

  12. Marie I, Heliot P, Roussel F, Herve F, Muir JF, Levesque H (2005) Fatal mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology 44:1201–1202

    Article  PubMed  CAS  Google Scholar 

  13. Roddy E, Courtney PA, Morris A (2002) Non-Hodgkin’s lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab. Rheumatology 41:1194–1195

    Article  PubMed  CAS  Google Scholar 

  14. Wilkes R, Sereika SM, Fertig N et al (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52:2439–2446

    Article  PubMed  CAS  Google Scholar 

  15. Gottenberg JE, Guillevin L, Lambotte O et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913–920

    Article  PubMed  CAS  Google Scholar 

  16. Lambotte O, Kotb R, Maigne G et al (2005) Efficacy of rituximab in refractory polymyositis. J Rheumatol 32:1368–1370

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Sperimentale, Università di Verona, P.le Scuro, 37134, Verona, Italy

    Paola Caramaschi, Alessandro Volpe, Antonio Carletto, Lisa M. Bambara & Domenico Biasi

Authors
  1. Paola Caramaschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Volpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Carletto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lisa M. Bambara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Domenico Biasi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paola Caramaschi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caramaschi, P., Volpe, A., Carletto, A. et al. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature. Clin Rheumatol 26, 1795–1796 (2007). https://doi.org/10.1007/s10067-006-0526-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0526-5

Keywords

Search

Navigation